Are you a new member? Sign up now
Login area
| Sign up
close
FABRAZYME - 35mg - 1
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A16AB04 | BioTech | Agalsidase beta - 35mg | 10155 | 118319/1 | FABRAZYME | 35mg | 1 | Injectable powder for concentrate for solution | Infusion | Mersaco | Genzyme Ireland Ltd | Ireland | 295,369,569 L.L | 2.44 | E2 | Genzyme Europe BV | The Netherlands | 2/5/2024 | 0 |
Drug Substitutes
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A16AB04 | BioTech | Agalsidase beta - 35mg | 10155/388 | 118319/1 | FABRAZYME | 35mg | 1 | Injectable powder for concentrate for solution | Infusion | Mersaco | Genzyme Ireland Ltd | Ireland | L.L | 2.44 | E2 | Genzyme Europe BV | The Netherlands | 2/5/2024 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024